Insider · CIK 0001811802

Weisman Howard J.

Reports to the SEC for 1 company · TARRYTOWN, NY

sec.gov

Transactions

Companies

Filings

CIK

0001811802

Forms 4 and 5

Insider transactions

16 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-03-12	Kuvatris Therapeutics, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−2,927 sh	$0.69	−$2,019.63	34,748
2024-01-29	Kuvatris Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−372 sh	$0.47	−$174.84	37,675
2023-11-27	Kuvatris Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−162 sh	$1.03	−$166.244	38,047
2023-10-27	Kuvatris Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−8,049 sh	$0.19	−$1,524.481	649,549
2023-08-30	Kuvatris Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−22.5K sh	$0.45	−$10.1K	657,598
2023-08-29	Kuvatris Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−9,596 sh	$0.48	−$4,650.222	680,133
2023-08-28	Kuvatris Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−12K sh	$0.49	−$5,858.4	689,729
2023-07-26	Kuvatris Therapeutics, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−9,952 sh	$0.72	−$7,135.584	701,729
2023-04-26	Kuvatris Therapeutics, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−9,952 sh	$1.61	−$16K	711,681
2023-04-13	Kuvatris Therapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+180K sh	—	—	721,633
2023-03-09	Kuvatris Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−3,495 sh	$1.44	−$5,032.8	541,633
2023-03-08	Kuvatris Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−32.4K sh	$1.46	−$47.3K	545,128
2023-03-07	Kuvatris Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−23.6K sh	$1.53	−$36K	577,525
2023-03-06	Kuvatris Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−13.6K sh	$1.72	−$23.4K	601,076
2023-03-03	Kuvatris Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−15.3K sh	$1.90	−$29.1K	614,665
2023-03-02	Kuvatris Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−11.7K sh	$1.94	−$22.7K	629,988

Recent filings

Accepted (ET)
Mar 144
Weisman Howard J.0001104659-24-034557
SEC(opens sec.gov)
Jan 314
Weisman Howard J.0001104659-24-008883
SEC(opens sec.gov)
Nov 294
Weisman Howard J.0001062993-23-021596
SEC(opens sec.gov)
Oct 304
Weisman Howard J.0001062993-23-019819
SEC(opens sec.gov)
Aug 304
Weisman Howard J.0001062993-23-017284
SEC(opens sec.gov)
Jul 284
Weisman Howard J.0001062993-23-015429
SEC(opens sec.gov)
Apr 284
Weisman Howard J.0001104659-23-052957
SEC(opens sec.gov)
Apr 144
Weisman Howard J.0001104659-23-045780
SEC(opens sec.gov)
Mar 94
Weisman Howard J.0001104659-23-030761
SEC(opens sec.gov)
Mar 74
Weisman Howard J.0001104659-23-029723
SEC(opens sec.gov)
Mar 34
Weisman Howard J.0001104659-23-028619
SEC(opens sec.gov)

Companies

Kuvatris Therapeutics, Inc.Director, Chief Executive Officer

Address

C/O PAXMEDICA, INC. 303 SOUTH BROADWAY, SUITE 125

TARRYTOWN, NY, 10591